Thyroid hormones maintain optimal metabolism and normal

Transcription

1 Original Article Prevalence and Pattern of Sick Euthyroid Syndrome in Acute and Chronic Non-thyroidal Illness Its Relationship with Severity and Outcome of the Disorder AH Zargar*, MA Ganie*, SR Masoodi*, BA Laway*, MI Bashir*, AI Wani*, M Salahuddin+ Abstract Background: Non-thyroidal illness is a common cause of alterations in thyroid hormone economy in absence of underlying intrinsic thyroid disorder. Objective: To study the prevalence and pattern of alterations in thyroid hormone economy in various non-thyroidal illnesses in our region and also to correlate these alterations with the severity and outcome of the non-thyroidal illness. Material and Methods: We analyzed circulating T3, T4, TSH in 382 patients with non-thyroidal illness (285 acute and 97 acute on chronic) and correlated the alterations with severity and outcome of the non-thyroidal disorder. The patients had one or more organ failure at the time of enrollment to the study. The hormones were estimated at the onset of sickness, and at 3rd and 24 th week. T3, T4 and TSH in 75 age and sex matched euthyroid subjects were taken as controls. Results: T3 (mean + SEM) was significantly reduced at the onset of illness, in both acute and chronic patient groups ( nmol/l) compared to that in the controls ( nmol/l). In spite of clinical improvement in most instances, T3 continued to remain low in the 3rd week ( nmol/ l) but increased ( nmol/l) in 24 th week. Low T3 was found in 93 (32.6%) cases with acute illness in 20 (20.6%) cases with chronic illness. A combination of low T3 and T4 was found in 35 (12.3%) of cases with acute and 15 (15.5%) with chronic illness. Although serum TSH showed noticeable fall and rise in some individuals, no significant difference in mean TSH was observed during any period of illness compared to that in the controls. Severity of illness correlated with decrease in T3 (r=0.58) and T4 (r=0.38). A low T3 and T4 with low or undetectable TSH were associated with increased mortality. At the onset of acute illness low T3 was seen in 113 (29.6%, low T3 -low T4 in 50 (13.1%), high T4 in 28 (7.3%) lowt3-lowt4- low TSH in 10 (2.6%) and low T4 alone in 4 (1%) patients. Fifty one (13.4%) of our patients demonstrated alterations in TSH in presence of normal T3 and T4-26 patients had decreased TSH while as 25 had increased TSH. Of 118 patients who followed at 24 weeks, 11(9.3%) had low T3, 7(5.9%) had low T3- low T4 and 13 (11%) had elevated TSH. Conclusion: Pattern and prevalence of sick euthyroid syndrome in this part of the world, a recognized iodine deficient region, appears to be similar to that reported elsewhere. Important finding in our study was higher percentage of TSH elevation, which we believe to reflect the underlying iodine deficiency state of our community. Besides a significant number of subjects persisted with alterations in thyroid functions even after 6 months of therapy. Though the severity of thyroid hormone derangement correlated with severity of sickness, the derangement was similar in acute vs. acute on chronic nonthyroidal illnesses. *Department of Endocrinology and +Immunology, Sher-i-kashmir Institute of Medical Sciences, Soura, Srinagar, Kashmir. Received : ; Revised : ; Re-revised : ; Accepted : INTRODUCTION Thyroid hormones maintain optimal metabolism and normal function of various organs. The normal thyroid hormone JAPI VOL. 52 JANUARY

2 economy (kinetics and dynamics) is regulated by suprathyroidal and intrathyroidal mechanisms and any tilt in the regulation may lead to alterations in the thyroid hormone function. Multiple alterations are known to occur in nonthyroidal illnesses (NTI) of varying severity. Most prominent of the changes are decrease in serum T3 and increased rt3 leading to low T3 syndrome. 1 However, more appropriate terms is sick euthyroid syndrome (SES) 2 since not only T3 but all other parameters, including T4 and TSH are often affected in NTI. The SES has also been described in liver disease, 3 renal failure, 4 after stress or surgery, 5, in elderly sick, 6 and after ingestion of drugs like amiodarone, 7 corticosteroids, 8 and propranolol. 9 The magnitude of changes in serum T3 and T4 do not depend on the type of illness but on its severity. 10 With progression in severity, serum T3 continues to fall to very low values in critical illness while serum T4 are normal, low or elevated. Most of the previous reports have generally been on small number of patients. 3-9 Hence this study was undertaken in a big cohort of patients with disorders of various systems with a significant number being followed up to 24 weeks. MATERIAL AND METHODS Study population : Two hundred and eighty five consecutive patients suffering from acute NTI and 97 patients of acute on chronic NTI, admitted to various departments of SKIMS, were enrolled for this study (Table 1). The inclusion criteria for acutely sick patients were presence of one or more organ failure as defined by modified APACHE-II scoring system for illness. 11 The inclusion criteria for chronically sick patients were an acute exacerbation of the underlying or intercurrent sickness needing admission to the hospital. The severity of acute on chronic sickness were defined by APACHE-II scoring system. 12 Patients were years old with nearly equal proportion from both sexes. Patients with clinical suggestion of intrinsic thyroid disease were excluded from the study. Seventy five healthy, age matched, subjects from both sexes were taken as controls. Methods : All patients, in addition to clinical assessment, were subjected to baseline investigations including a haemogram, blood urea nitrogen, creatinine, glucose, bilirubin, aspartate aminotransferase, alanine aminotransferase, alkaline phosphatase, calcium, phosphorus and electrolytes, arterial blood gas analysis, urine examination, 12-lead electrocardiogram and X-ray chest. Blood samples were obtained at the onset, at three weeks and at 24 weeks in acutely ill while in those with chronic sickness, samples were taken at the time of admission and others at three and 24 weeks of followup. One blood sample for T3, T4 and TSH was taken from all controls. T3, T4 and TSH were estimated using specific radioimmunoassay (RIA) kits obtained from Bharat Radiation Isotope Technology (BRIT), Mumbai, India. The intra-and interassay coefficient of variation was less than 5% and less than 10% respectively. Definitions : Depending upon the changes in T3, T4 and TSH and their various combinations, various thyroid hormone alterations were categorized into: low T3 syndrome, low T3- low T4 syndrome, low T3-low T4-low TSH (all low), high T4 (normal T3 and TSH), high TSH (normal T3 and T4), low TSH (normal T3 and T4), and low T4 (normal T3 and TSH) variants. Statistical Analysis : Statistical analysis was performed using the SPSS (Statistical Programme for the Social Sciences, version 6.0) software on an IBM-compatible computer. All the results, unless otherwise noted were expressed as mean ± SEM. In addition to descriptive statistics, various nonparametric tests were used to assess the association between categorical variables and the t-test for comparison among continuous variables. Other methods of statistical analysis included one way analysis of variance (ANOVA) and the multiple linear regression model. A P value of < 0.05 (twotailed) was considered significant. RESULTS Of 285 subjects with acute sickness, 32 patients died; most others recovered fully, but among them, only 95 were available for sample collection at three weeks and 84 patients, at 24 weeks. Of 97 patients with chronic sickness, 47 were available for second sample at three weeks and 34 for third sample at 24th week. Fig. 1 shows the age distribution of patients and controls. The mean ( ± SEM) age was ± 0.77 years in patients with Fig. 1 : Age distribution of patients and controls. Table 1 : Distribution of cases as per type of illness (system involved) Illness No. of patients (%) Overall Acute Chronic Cardiovascular 91 (23.8) 66 (23.1) 25 (25.8) Renal 73 (19.1) 54 (18.9) 19 (19.6) Neurological 34 (8.9) 31 (10.9) 3 (3.1) Malignancy 33 (8.6) 25 (8.8) 8 (8.2) Gastrointestinal 25 (6.6) 18 (6.3) 7 (7.2) Sepsis 18 (4.7) 15 (5.3) 3 (3.1) Chest 17 (4.5) 13 (4.6) 4 (4.1) Haematological 10 (2.6) 6 (2.1) 4 (4.1) Surgery and trauma 10 (2.6) 8 (2.8) 2 (2.1) Poisoning 3 (0.8) 3 (1.1) Miscellaneous 68 (17.8) 46 (16.1) 22 (22.7) All illness 382 (100) 285 (100) 97 (100) 28 JAPI VOL. 52 JANUARY 2004

3 Table 2 : Influence of severity on thyroid hormone profile (mean ± SEM) Hormone Group I Group II Group III (APACHE < 16) (APACHE 16-20) (APACHE > 20) p value* A (0 wk) 2.29 ± ± ± 0.08 < (S) B (3 wks) 2.14 ± ± ± (S) C (24 wks) 2.75 ± ± ± (S) A (0 wk) ± ± ± 5.40 < (S) B (3 wks) ± ± ± C (24 wks) ± ± ± (S) A (0 wk) 2.84 ± ± ± B (3 wks) 4.35 ± ± ± C (24 wks) 6.82 ± ± ± *Analysis of variance (ANOVA) Table 3 : Thyroid hormone profile - acute versus chronic (mean ± SEM) Hormone Non-thyroidal illness Acute Chronic p value Fig. 2 : Overall T3, T4 and TSH in the study population. acute sickness, ± 1.08 years in patients with chronic sickness and ± 1.43 years in controls. Patients with diseases of cardiovascular system, renal system, neurological system, gastrointestinal system and malignancies constituted the bulk of the study population (Table 1). Overall, mean total T3 levels were significantly reduced at the onset of the sickness and continued to be low at three weeks. Even at six months (24 weeks), when it had shown a significant improvement, mean T3 continued to be low in comparison to controls (Fig. 2). Serum T4 and TSH did not show significant differences from controls during the course of the sickness. In patients with NTI, age had no influence on serum thyroid hormone levels. Comparison of total T3, T4 and TSH at onset, three weeks and 24 weeks of acute sickness or acute on chronic sickness between age groups of < 40 years and > 40 years was not statistically significant. A twotailed t test and P value was used to compare the two groups. Using the same statistical parameters there was no difference in T3, T4 and TSH in control groups of < 40 years and > 40 years. Mean T3 was significantly lower in males as compared to females at the onset of illness. However, there was no significant difference in mean T4 and TSH between the two sexes. The study results indicate highly significant correlation between severity of sickness and fall of T3 and T4 with a correlation coefficient (r) of 0.58 and 0.38, respectively. In patients with an APACHE score less than 16, T3 had become A (0 wk) 1.55 ± ± (S) B (3 wks) 1.47 ± ± (NS) C (24 wks) 2.15 ± ± (NS) A (0 wk) ± ± (NS) B (3 wks) ± ± (NS) C (24 wks) ± ± (NS) A (0 wk) 2.72 ± ± (NS) B (3 wks) 3.50 ± ± (NS) C (24 wks) 4.19 ± ± (NS) S - significant, NS - non-significant Table 4 : Prevalence of SES at onset of NTI and at follow-up SES variant 0 week 3 weeks 24 weeks (n=382) (n=142) (n=118) Low T3 113 (29.6) 40 (28.2) 11 (9.3) Low T3-low T4 50 (13.1) 23 (16.2) 7 (5.9) High T4 28 (7.3) 13 (9.2) 8 (6.8) Low TSH 26 (6.8) 9 (6.3) 6 (5.1) High TSH 25 (6.5) 12 (8.4) 13 (11.0) All low 10 (2.6) 3 (2.1) 5 (4.2) Low T4 4 (1.0) 1 (0.8) All variants 256 (67.0)* 100 (70.4)* 51 (43.2)* *c2df2=26.3, P < comparable to that of controls by 24 weeks whereas it continued to be significantly low in patients with an APACHE score of 16 or more (Table 2). Analysis of the data separately for acute and acute on chronic illness showed similar correlation of thyroid hormone alteration with severity of sickness. In both acute as well as acute on chronic sickness, serum T3 was significantly low at the onset of illness (1.55 ± 0.06, 1.47 ± 0.11 and 2.15 ± 0.11 nmol/l in acute, in 1.81 ± 0.11, 1.55 ± 0.26 and 2.09 ± 0.17 nmol/l in chronic at 0, 3 and 24 weeks, respectively), whereas, T4 and TSH did not show any significant alterations (Table 3). JAPI VOL. 52 JANUARY

4 Table 5 : Relationship between outcome of NTI and thyroid hormone results Hormone 0 week 3 weeks Live Dead p value Live Dead p value Acute 1.43 ± ± 0.09 < (S) 1.72 ± ± 0.15 < (S) Chronic 1.49 ± ± (S) 1.72 ± ± (S) Overall 1.45 ± ± 0.08 < (S) 1.72 ± ± 0.13 < (S) Acute ± ± 6.80 < ± ± (S) Chronic ± ± (S) ± ± < (S) Overall ± ± 5.97 < 0.01 (S) ± ± 5.20 < (S) Acute 3.68 ± ± ± ± Chronic 2.31 ± ± ± ± Overall 3.38 ± ± ± ± S - significant The incidence of SES at the onset of illness was 67.0% and this was not significantly different at third week of illness (70.4%) but showed a decline at 24 weeks (43.2%) (Table 4). Overall there was no difference in the incidence of SES between acute and acute on chronic NTI groups (Table 3). However, among acute NTI group a higher percentage had elevated TSH at 24 weeks as compared to acute on chronic NTI (22.7% vs. 8.8%). At the conclusion of the study 38 patients (32 from acute groups and six from chronic group) had expired. Table 5 gives the details of hormone profile of alive and expired patients showing significantly low T3 and T4 at beginning as well as at three weeks in patients who expired. DISCUSSION This study showed that age has no influence on thyroid hormone alteration in NTI, which was also concluded in an earlier study. 6 A recent study also reported high prevalence of SES in elderly subjects undergoing surgery. 13 An earlier report suggested that age does not influence these alterations. 14 We observed that T3 and T4 showed a significant fall at the onset of the sickness compared to controls and in spite of the clinical recovery in most of the patients by third week, T3 and T4, demonstrated a further fall and it was only at six months that a significant evidence of recovery could be observed even at six months, although mean T4 became comparable to control values, T3 still remained low, versus that in controls. Interestingly, although TSH showed a significant fall and rise in some individual cases, there was no overall difference in the mean TSH at any period of observation. Analysis of data for acute, and acute events in chronic illnesses showed similar correlation of hormone alteration with severity of sickness. At the onset of sickness, mean T3 was significantly low in patients with acute NTI than with those with acute on chronic NTI (Table 3). This pattern of hormone profile has been by now declared as a consistent feature of SES. 2,7,15 The unusual features of this study are that T3 and T4 continued to be low at three weeks even when clinical recovery had taken place; T3 continued to be low even at six months. In patients with APACHE score of more than 20, serum T3 and T4 was the lowest. This observation is consistent with earlier published data. 13 In this study, 29.6% had low T3, 13.1% had low T3-low T4, 7.3% had high T4 alone, 2.6% had low T3-low T4-low TSH, 1% had low T4 alone, and 13.4% patients had abnormality of TSH at the onset of NTI, giving an overall prevalence of 67% of SES, as at first observation, 70.5%, at three weeks, 43.2% at 24 weeks. Earlier studies have documented prevalence of SES from 45% to 84% Low serum total T3 is the most common abnormality in NTI. It is observed in about 70% of hospitalized patients, 19 but in one study, this was observed in 29.6% only. Low T3 is attributed to decreased peripheral production and for increased T3 metabolic clearance. 15 Low T3-low T4 syndrome is observed in severely ill, frequently moribund, patients; 50 (13.1%) of our patients had this variant of SES at the beginning of sickness. At six months, seven patients who followed continued to have low T3 and T4. In addition to 50 patients mentioned above, ten more patients had low T3 and low T4 along with low TSH. The incidence of this variant has been reported as 6.5% 14 and 29%. 15 Low serum total T4 correlates with bad prognosis. 20 Four of our patients had low T4 alone. This small group of patients had a mean APACHE score of 12 indicating that the sickness was not severe. Besides low TSH, factors that may contribute to the low T4 of NTI include abnormalities in TSH secretion, decreased biological activity of TSH and diminished thyroidal response to TSH. One percent of our patients had high T4 variant of SES at the onset of sickness. This variant has been demonstrated in cases of drug therapy and organophosphorus poisoning. 16 High serum total T4 is seen in some NTI patients, who have elevated serum concentration of TBG. Two each of our four patients with high T4 had organosphosphorus poisoning and liver disease. Fifty-one of our patients had alterations of TSH alone; 26 (6.8%) of them had decreased TSH whereas 25 (6.5%) had elevated TSH. Unlike T3 and T4 the percentage of patients with elevated TSH increased to 8.2% by third week and 11% by 24 weeks. In acute group a higher percentage of patients had elevated TSH at 24 weeks as compared to chronic group (22.7% vs. 8.8%). Many authors have reported a lower mean 30 JAPI VOL. 52 JANUARY 2004

5 TSH concentration in a group of NTI patients compared to controls and a higher incidence of suppressed serum TSH values in NTI. The transient increase in TSH during recovery from NTI suggests that TSH is suppressed in an illness. The pattern of hormone profile described above has by now been declared a consistent feature SES. Most of our patients are from the valley which is a recognized iodine deficient region, thus iodine deficiency per se seems not to influence the prevalence and pattern of euthyroid sick syndrome. The behaviour of thyroid profile of acute NTI was not different from acute on chronic NTI. Severe derangement of either T3 or T4 level was highly correlated with eventual mortality. The important finding of our study is the persistence of thyroid hormone abnormalities in significant number of patients even at six months. High TSH in our study could be due to increased prevalence of iodine deficiency in this part of the world. Many believe that patients with SES are metabolically euthyroid eventhough serum levels of T3, are in the hypothyroid range. Some of these patients, particularly those with prolonged NTI, may indeed be biochemically hypothyroid and may benefit from treatment with thyroid hormone. 15 Persistence of changes in thyroid hormone in a good number of our patients seen at six months, seems to lend support to this belief. However, a longer follow-up would be required to confirm their hypothyroid/euthyroid status. REFERENCES 1. Wartofsky L, Burman KD. Alterations in thyroid function in patients with systemic illness: the Euthyroid sick syndrome. Endocrine Review 1982;3: Carter JN, Eastman CJ, Corcoran JM, Lazarus L. Effect of severe chronic illness on thyroid function. Lancet 1974;2: Chopra IJ, Solomon DH, Chopra U, Young RT, Chua-Teco GN. Alterations in circulating thyroid hormone and thyrotropin in hepatic cirrhosis, evidence of euthyroidism despite subnormal serum triiodothyronine. J Clin Endocrinol Metab 1974;39: Finucane JF, Griffiths RS, Black EG, Hall CL. Effects of chronic renal disease on thyroid hormone metabolism. Acta Endocrinol 1977;84: Burr WA, Griffiths RS, Black EG, Hoffenberg RA, Meinhold H, Wenzel KW. Serum triiodothyronine and reverse triiodothyronine concentrations after surgical operations. Lancet 1975;2: Burrows AW, Cooper E, Shakespeare RA. Low serum T3 in elderly sick; protein binding, thyroid and pituitary responsiveness and reverse T3 in elderly sick; protein binding, thyroid and pituitary responsiveness and reverse T3 concentrations. Clin Endocrinol 1977;7: Burger A, Dinichert D, Nicod P. Effect of amiodarone on serum triiodothyronine, reverse triiodothyronine, thyroxine and thyrotropin. J Clin Investigation 1976;58: Chopra IJ, Williams DE, Orgiazzi J, Soloman DH. Opposite effects of dexamethasone on serum concentrations of 3, 3-5 -triiodothyronine (reverse T3) and 3, 3,5-triiodothyronine (T3). J Clin Endocrinol Metab 1975;41: Verhoeven RP, Visser TJ, Docter R. Plasma thyroxine, 3,3-5-triiodothyronine and 3,3,5-triiodothyronine during B- adrenergic blockade in hyperthyroidism. J Clin Endocrinol Metab 1977;44: Kaptein EM. Thyroid hormone metabolism in illness. In: Hennemann G (ed.) Thyroid Hormone Metabolism. Marcel Dekker, New York. 1986; Knaus WA, Draper EA, Wagner DP. APACHE II - severity of disease classification system. Critical Care Medicine 1981;9: Knaus WA, Zimmerman JE, Wagner DP. APACHE - Acute physiology and chronic health evaluation: A physiologically based classification system. Critical Care Medicine 1981;9: Girvent M, Maestro S, Hernandez R, Carajol I, Mome J, Sancho JJ, Gubeen JM, Sitges-Serra A. Euthyroid sick syndrome, associated endocrine abnormalities in elderly undergoing operation. Surgery 1998;123: Shimamoto Y, Schimamoto H, Nakamora H. Factors influencing serum free T3 and free T4 in elderly euthyroid subjects. Japanese J Geriatrics Nippon Routh Igakkai Zashi 1989;26: Brent GA, Hershman GM, Braunstein GD. Patients with severe nonthyroidal illness and low serum thyroxine concentration. Am J Med 1986;81: Tseng FY, Chen CS. Thyroid function tests in acute drug intoxication (Chinese). J Formosan Med Assoc 1992;1: Loh KC, Eng PC. Prevalence and prognostic relevance of sick euthyroid syndrome in a medical intensive care unit. Ann Acad Med, Singapore 1995;24: Gomez JM, Virgili N, Navarrom A, Roca M, Moutana E, Soler J. Study of thyroid function parameters and thyrotropin in general nonthyroid disease. Medicina Clinical 1989;91: Chopra IJ. Euthyroid sick syndrome : is it a misnomer? J Clin Endocrinol Metab 1997;82: Slag MF, Morley JE, Elson MK, Crowson TW, Nettle FQ, Shafer RB. Hyperthyroxinemia in critically ill paients as a predictor of high mortality. JAMA 1981;245: Wehmann RE, Gregerman RI, Burns WH, Saral R, Santos GW. Suppression of thyrotropin in the low-thyroxine state of severe non-thyroidal illness. N Engl J Med 1985;31: Zargar AH, Shah JA, Mir MM, Laway BA, Masoodi SR, Shah NA. Prevalence of goiter in school-children in Kashmir Valley. Am J Clin Nutr 1995;62: JAPI VOL. 52 JANUARY